162 related articles for article (PubMed ID: 7848887)
1. Primary mediastinal large cell lymphoma is characterized by an inverted pattern of large tumoral mass and low beta 2 microglobulin levels in serum and frequently elevated levels of serum lactate dehydrogenase.
Rodriguez J; Pugh WC; Romaguera JE; Luthra R; Hagemeister FB; McLaughlin P; Rodriguez MA; Swan F; Cabanillas F
Ann Oncol; 1994 Nov; 5(9):847-9. PubMed ID: 7848887
[TBL] [Abstract][Full Text] [Related]
2. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA ("Groupe d'Etude des Lymphomes de l'Adulte") study.
Cazals-Hatem D; Lepage E; Brice P; Ferrant A; d'Agay MF; Baumelou E; Brière J; Blanc M; Gaulard P; Biron P; Schlaifer D; Diebold J; Audouin J
Am J Surg Pathol; 1996 Jul; 20(7):877-88. PubMed ID: 8669537
[TBL] [Abstract][Full Text] [Related]
3. Primary mediastinal large B-cell lymphoma: a single-center study of clinicopathologic characteristics.
Kolonić SO; Dzebro S; Kusec R; Planinc-Peraica A; Dominis M; Jaksić B
Int J Hematol; 2006 May; 83(4):331-6. PubMed ID: 16757434
[TBL] [Abstract][Full Text] [Related]
4. High-dose chemotherapy for relapsed and refractory diffuse large B-cell lymphoma: mediastinal localization predicts for a favorable outcome.
Popat U; Przepiork D; Champlin R; Pugh W; Amin K; Mehra R; Rodriguez J; Giralt S; Romaguera J; Rodriguez A; Preti A; Andersson B; Khouri I; Claxton D; de Lima M; Donato M; Anderlini P; Gajewski J; Cabanillas F; van Besien K
J Clin Oncol; 1998 Jan; 16(1):63-9. PubMed ID: 9440724
[TBL] [Abstract][Full Text] [Related]
5. Primary cutaneous non-Hodgkin's lymphoma with aggressive histology: inferior outcome is associated with peripheral T-cell type and elevated lactate dehydrogenase, but not extent of cutaneous involvement.
Visco C; Medeiros LJ; Jones D; Smith T; Rodriguez MA; McLaughlin P; Romaguera J; Cabanillas F; Sarris AH
Ann Oncol; 2002 Aug; 13(8):1290-9. PubMed ID: 12181254
[TBL] [Abstract][Full Text] [Related]
6. [Treatment of primary mediastinal large B-cell lymphomas].
Schneider T; Tóth E; Molnár Z; Várady E; Deák B; Horváth A; Horváth GI; Eid H; Schneider K; Lovey J; Keresztes S; Esik O; Lengyel Z; Rosta A
Orv Hetil; 2004 Dec; 145(50):2531-7. PubMed ID: 15662753
[TBL] [Abstract][Full Text] [Related]
7. [Mediastinal large B-cell lymphoma. A retrospective anatomic-clinical study of 26 cases].
Tchen N; Eghbali H; Soubeyran P; Trojani M; Richaud P; Bonnel C; Quénel-Tueux N; Hoerni B
Bull Cancer; 1997 Jul; 84(7):704-8. PubMed ID: 9339196
[TBL] [Abstract][Full Text] [Related]
8. Induction chemotherapy strategies for primary mediastinal large B-cell lymphoma with sclerosis: a retrospective multinational study on 426 previously untreated patients.
Zinzani PL; Martelli M; Bertini M; Gianni AM; Devizzi L; Federico M; Pangalis G; Michels J; Zucca E; Cantonetti M; Cortelazzo S; Wotherspoon A; Ferreri AJ; Zaja F; Lauria F; De Renzo A; Liberati MA; Falini B; Balzarotti M; Calderoni A; Zaccaria A; Gentilini P; Fattori PP; Pavone E; Angelopoulou MK; Alinari L; Brugiatelli M; Di Renzo N; Bonifazi F; Pileri SA; Cavalli F;
Haematologica; 2002 Dec; 87(12):1258-64. PubMed ID: 12495899
[TBL] [Abstract][Full Text] [Related]
9. Soluble intercellular adhesion molecule-1 (s-ICAM-1/s-CD54) in diffuse large B-cell lymphoma: association with clinical characteristics and outcome.
Terol MJ; Tormo M; Martinez-Climent JA; Marugan I; Benet I; Ferrandez A; Teruel A; Ferrer R; García-Conde J
Ann Oncol; 2003 Mar; 14(3):467-74. PubMed ID: 12598355
[TBL] [Abstract][Full Text] [Related]
10. Salvage chemotherapy and autologous stem cell transplantation are inferior for relapsed or refractory primary mediastinal large B-cell lymphoma compared with diffuse large B-cell lymphoma.
Kuruvilla J; Pintilie M; Tsang R; Nagy T; Keating A; Crump M
Leuk Lymphoma; 2008 Jul; 49(7):1329-36. PubMed ID: 18604722
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors and treatment of patients with T-cell non-Hodgkin lymphoma: the M. D. Anderson Cancer Center experience.
Escalón MP; Liu NS; Yang Y; Hess M; Walker PL; Smith TL; Dang NH
Cancer; 2005 May; 103(10):2091-8. PubMed ID: 15816054
[TBL] [Abstract][Full Text] [Related]
12. Primary mediastinal large B-cell lymphoma: a clinicopathologic study of 43 patients from the Nebraska Lymphoma Study Group.
Abou-Elella AA; Weisenburger DD; Vose JM; Kollath JP; Lynch JC; Bast MA; Bierman PJ; Greiner TC; Chan WC; Armitage JO
J Clin Oncol; 1999 Mar; 17(3):784-90. PubMed ID: 10071267
[TBL] [Abstract][Full Text] [Related]
13. Primary mediastinal large B-cell lymphoma: clinical study of a distinct clinical entity and treatment outcome in 20 patients: review of the literature.
Andreopoulou E; Pectasides D; Dimopoulos MA; Nikolaides C; Fountzilas G; Valsami S; Economopoulos T
Am J Clin Oncol; 2004 Jun; 27(3):312-6. PubMed ID: 15170155
[TBL] [Abstract][Full Text] [Related]
14. The management of primary mediastinal B-cell lymphoma with sclerosis.
Brugger W; Engelhardt R; Mertelsmann R; Kanz L
Ann Oncol; 1994 Dec; 5(10):943-7. PubMed ID: 7535081
[No Abstract] [Full Text] [Related]
15. Primary mediastinal large B-cell lymphoma: a single-institution clinical study in Japan.
Sekiguchi N; Nishimoto J; Tanimoto K; Kusumoto S; Onishi Y; Watanabe T; Kobayashi Y; Asamura H; Kagami Y; Matsuno Y; Tobinai K
Int J Hematol; 2004 Jun; 79(5):465-71. PubMed ID: 15239397
[TBL] [Abstract][Full Text] [Related]
16. Value of serum beta 2 microglobulin as an indicator of early relapse in diffuse large cell lymphoma.
Avilés A; Narváez BR; Díaz-Maqueo JC; Guzmán R; Talavera A; García EL
Leuk Lymphoma; 1993 Mar; 9(4-5):377-80. PubMed ID: 7688627
[TBL] [Abstract][Full Text] [Related]
17. Primary mediastinal large B-cell lymphoma: the need for prospective controlled clinical trials.
Bieri S; Roggero E; Zucca E; Bertoni F; Pianca S; Sanna P; Pedrinis E; Bernier J; Cavalli F
Leuk Lymphoma; 1999 Nov; 35(5-6):537-44. PubMed ID: 10609791
[TBL] [Abstract][Full Text] [Related]
18. [Clinical characteristics and prognosis of diffuse large B-cell lymphoma].
Yang BY; Yong WB; Zhu J; Zheng W; Zhang YT; Wang XP; Meng SN
Zhonghua Zhong Liu Za Zhi; 2005 Mar; 27(3):174-6. PubMed ID: 15946571
[TBL] [Abstract][Full Text] [Related]
19. MACOP-B and involved-field radiotherapy is an effective and safe therapy for primary mediastinal large B cell lymphoma.
De Sanctis V; Finolezzi E; Osti MF; Grapulin L; Alfò M; Pescarmona E; Berardi F; Natalino F; Moleti ML; Di Rocco A; Enrici RM; Foà R; Martelli M
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1154-60. PubMed ID: 18472357
[TBL] [Abstract][Full Text] [Related]
20. Risk classification for large cell lymphoma using lactate dehydrogenase, beta-2 microglobulin, and thymidine kinase.
Suki S; Swan F; Tucker S; Fritsche HA; Redman JR; Rodriguez MA; McLaughlin P; Romaguera J; Hagemeister FB; Velasquez WS
Leuk Lymphoma; 1995 Jun; 18(1-2):87-92. PubMed ID: 8580834
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
